Electromed, Inc. (ELMD) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2021-12-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2021-12-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2021-12-31..
Borrowing debt
Overview →Financial period ending 2021-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2021-12-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2021-12-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2021-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 51.00K USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | (m) | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 38.20M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | (m) | (m) | $51.00K | (m) | (m) | (m) | $38.20M | (m) |
| 2021-09-30 | (m) | (m) | $69.00K | (m) | (m) | (m) | $37.90M | (m) |
| 2021-06-30 | (m) | (m) | $33.00K | (m) | (m) | (m) | $37.11M | (m) |
| 2021-03-31 | (m) | (m) | $40.68K | (m) | (m) | (m) | $37.17M | (m) |
| 2020-12-31 | (m) | (m) | $40.45K | (m) | (m) | (m) | $35.82M | (m) |
| 2020-09-30 | (m) | (m) | $55.32K | (m) | (m) | (m) | $34.39M | (m) |
| 2020-06-30 | (m) | (m) | $72.33K | (m) | (m) | (m) | $33.24M | (m) |
| 2020-03-31 | (m) | (m) | $76.87K | (m) | (m) | (m) | $32.97M | (m) |
| 2019-12-31 | (m) | (m) | $82.94K | (m) | (m) | (m) | $31.49M | (m) |
| 2019-09-30 | (m) | (m) | $82.70K | (m) | (m) | (m) | $30.30M | (m) |
| 2019-06-30 | (m) | (m) | $30.32K | (m) | (m) | (m) | $29.40M | (m) |
| 2018-09-30 | (m) | (m) | $1.09M | (m) | (m) | (m) | $27.51M | (m) |
| 2018-06-30 | (m) | (m) | $1.10M | (m) | (m) | (m) | $26.64M | (m) |
| 2018-03-31 | (m) | (m) | $1.11M | (m) | (m) | (m) | $24.26M | (m) |
| 2017-12-31 | (m) | (m) | $1.12M | (m) | (m) | (m) | $23.70M | (m) |
| 2017-09-30 | (m) | (m) | $51.21K | $1.09M | (m) | (m) | $23.21M | (m) |
| 2017-06-30 | (m) | (m) | $50.70K | $1.10M | (m) | (m) | $23.06M | (m) |
| 2017-03-31 | (m) | (m) | $50.20K | $1.11M | (m) | (m) | $21.90M | (m) |
| 2016-12-31 | (m) | (m) | $49.72K | $1.12M | (m) | (m) | $20.71M | (m) |
| 2016-09-30 | (m) | (m) | $44.96K | $1.14M | (m) | (m) | $19.70M | (m) |
| 2016-06-30 | (m) | (m) | $46.31K | $1.16M | (m) | (m) | $20.59M | (m) |
| 2016-03-31 | (m) | (m) | $47.63K | $1.17M | (m) | (m) | $20.01M | (m) |
| 2015-12-31 | (m) | (m) | $48.77K | $1.18M | (m) | (m) | $19.05M | (m) |
| 2015-09-30 | (m) | (m) | $49.41K | $1.19M | (m) | (m) | $17.63M | (m) |
| 2015-06-30 | (m) | (m) | $48.75K | $1.20M | (m) | (m) | $17.41M | (m) |
| 2015-03-31 | (m) | (m) | $48.10K | $1.21M | (m) | (m) | $16.99M | (m) |
| 2014-12-31 | (m) | (m) | $47.13K | $1.23M | (m) | (m) | $16.68M | (m) |
| 2014-09-30 | (m) | (m) | $47.00K | $1.24M | (m) | (m) | $16.52M | (m) |
| 2014-06-30 | (m) | (m) | $46.38K | $1.25M | (m) | (m) | $15.79M | (m) |
| 2014-03-31 | (m) | (m) | $45.76K | $1.26M | (m) | (m) | $16.10M | (m) |
| 2013-12-31 | (m) | (m) | $45.16K | $1.27M | (m) | (m) | $17.40M | (m) |
| 2013-09-30 | (m) | (m) | $52.66K | $1.32M | (m) | (m) | $17.41M | (m) |
| 2013-06-30 | (m) | (m) | $57.54K | $1.33M | (m) | (m) | $17.56M | (m) |
| 2013-03-31 | (m) | (m) | $1.39M | $18.33K | (m) | (m) | $18.84M | (m) |
| 2012-12-31 | (m) | (m) | $66.19K | $1.36M | (m) | (m) | $19.14M | (m) |
| 2012-09-30 | (m) | (m) | $159.87K | $1.37M | (m) | (m) | $20.44M | (m) |
| 2012-06-30 | (m) | (m) | $254.02K | $1.39M | (m) | (m) | $20.92M | (m) |
| 2012-03-31 | (m) | (m) | $351.48K | $1.40M | (m) | (m) | $20.82M | (m) |
| 2011-12-31 | (m) | (m) | $437.30K | $1.43M | (m) | (m) | $20.73M | (m) |
| 2011-09-30 | (m) | (m) | $403.75K | $1.51M | (m) | (m) | $21.17M | (m) |
| 2011-06-30 | (m) | (m) | $438.27K | $1.58M | (m) | (m) | $20.87M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDAP TMS SA (FOCL) | $0.171B | ||
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |